October 29, 2024

Anti-Obesity Medications Show Whole-Body Promise, With More to Come

(Medscape) – The potential of glucagon-like peptide 1 (GLP-1) receptor agonists continues to grow more promising as new studies identify benefits beyond glucose control and weight loss. With hundreds of studies underway or recently completed on ClinicalTrials.gov, the signals are … Read More